NURSING EXAM TEST
[Author name]
[COMPANY NAME] [Company address]
,1
Review Test Submission: Week
11 Final Exam
User
Course NURS-6630C-8/NURS-6630N-8-Approaches to Treatment2020
Spring Qtr 02/24-05/17-PT27
Test Week 11 Final Exam
Started 5/6/20 5:30 AM
Submitted 5/6/20 7:30 AM
Due Date 5/11/20 1:59 AM
Status Completed
Attempt 74 out of 75 points
Score
Time Elapsed 2 hours, 0 minute out of 2 hours
Results Submitted Answers
Displayed
Brandon is a non-compliant patient that presents to the clinic asking for help with his
alcohol dependence. The PMHNP evaluates the patient and determines a long-acting
injection that blocks the mu-receptors would be the best treatment option for Brandon.
Which medication should the PMHNP prescribe?
Selected c.
Answer: Naltrexone
(VIVITROL)
Sandra complains of constipation after being on quetiapine (SEROQUEL) for several
weeks. Constipation is likely caused by the binding of quetiapine (SEROQUEL) to which
receptor?
,2
Selected b.
Answer: D
1
, 3
Even though both of these medications are useful in the treatment of ADHD, their actions
are different. Atomoxetine is a selective reuptake inhibitor, while
bupropion is a selective reuptake inhibitor.
Selected d.
Answer: Norepinephrine / norepinephrine-
dopamine
An adult patient presents with a history of alcohol addiction and attention deficit
hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP determines which
of the following medications may be the best treatment option?
Selected d.
Answer: Atomoxetine
(Strattera)
The PMHNP is attempting to treat a patient’s chronic insomnia and wishes to start with
an initial prescription that has a half-life of approximately 1–2 hours. What is the most
appropriate prescription for the PMHNP to make?
Selected b.
Answer: Triazolam
(Halcion)
A patient with chronic insomnia and depression is taking trazodone (Oleptro) but
complains of feeling drowsy during the day. What can the PMHNP do to reduce the drug’s
daytime sedating effects?
Selected d.
Answer:
[Author name]
[COMPANY NAME] [Company address]
,1
Review Test Submission: Week
11 Final Exam
User
Course NURS-6630C-8/NURS-6630N-8-Approaches to Treatment2020
Spring Qtr 02/24-05/17-PT27
Test Week 11 Final Exam
Started 5/6/20 5:30 AM
Submitted 5/6/20 7:30 AM
Due Date 5/11/20 1:59 AM
Status Completed
Attempt 74 out of 75 points
Score
Time Elapsed 2 hours, 0 minute out of 2 hours
Results Submitted Answers
Displayed
Brandon is a non-compliant patient that presents to the clinic asking for help with his
alcohol dependence. The PMHNP evaluates the patient and determines a long-acting
injection that blocks the mu-receptors would be the best treatment option for Brandon.
Which medication should the PMHNP prescribe?
Selected c.
Answer: Naltrexone
(VIVITROL)
Sandra complains of constipation after being on quetiapine (SEROQUEL) for several
weeks. Constipation is likely caused by the binding of quetiapine (SEROQUEL) to which
receptor?
,2
Selected b.
Answer: D
1
, 3
Even though both of these medications are useful in the treatment of ADHD, their actions
are different. Atomoxetine is a selective reuptake inhibitor, while
bupropion is a selective reuptake inhibitor.
Selected d.
Answer: Norepinephrine / norepinephrine-
dopamine
An adult patient presents with a history of alcohol addiction and attention deficit
hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP determines which
of the following medications may be the best treatment option?
Selected d.
Answer: Atomoxetine
(Strattera)
The PMHNP is attempting to treat a patient’s chronic insomnia and wishes to start with
an initial prescription that has a half-life of approximately 1–2 hours. What is the most
appropriate prescription for the PMHNP to make?
Selected b.
Answer: Triazolam
(Halcion)
A patient with chronic insomnia and depression is taking trazodone (Oleptro) but
complains of feeling drowsy during the day. What can the PMHNP do to reduce the drug’s
daytime sedating effects?
Selected d.
Answer:
